Skip to main content
Clinical Trials/NCT03726697
NCT03726697CompletedNot Applicable

Effect of Tahneek With Dates on Hypoglycemia in Newborn Infants: A Randomised Control Trial

King Abdullah International Medical Research Center1 site in 1 country324 target enrollmentStarted: November 1, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
324
Locations
1
Primary Endpoint
Admission to NICU for hypoglycemia

Study Overview

Brief Summary

Tahneek is an Arabic word which means putting something sweet such as dates, in the infant's mouth after the birth. Neonatal hypoglycemia is common in the first few days after birth. Up to 15 % of normal newborn babies will have low blood glucose concentrations. It has been demonstrated that treatment of neonatal hypoglycemia with oral dextrose gel was more effective than feeding alone in reversing the hypoglycemia, and also reduced the rate of NICU admission. investigators study is using dates to asses its effect on hypoglycemia in infants at risk.

Detailed Description

Tahneek is an Arabic word which means putting something sweet such as dates, in the infant's mouth after the birth. It is a noble practice in Islam, with which the newborn is greeted upon entering into life, usually before milk feeds. It is done by rubbing a softened date on the palate of the new-born just after the birth. The tahneek also exercises the muscles of the mouth and helps with the circulation of blood in the mouth - this may help the baby to be able to suck and take mother's milk. Neonatal hypoglycemia is common in the first few days after birth. Up to 15 % but the incidence in babies with risk factors is much greater upto 50 % in infants of diabetic mothers, large and small babies and 66 % in preterm babies. Neonatal hypoglycemia is associated with brain damage, death and developmental delay in later life. Treatment of neonatal hypoglycemia with oral dextrose gel was more effective than feeding alone in reversing hypoglycemia, and thus reducing the rate of NICU admission for hypoglycemia. investigators study is using dates to asses its effect on hypoglycemia in infant at risk.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Outcomes Assessor)

Masking Description

Parents and Statistician are blinded

Eligibility Criteria

Ages
— to 1 Hour (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Babies at risk of hypoglycemia less than 1 hour old admitted to the normal nursery.
  • •Infants of diabetic mothers (any type of diabetes)
  • •Late Preterms (34 - 37 weeks' gestation)
  • •Low birth weight (< 2.5 kg ) or Small for gestational age
  • •Large for gestational age (> 4 kg or > 90th centile on Fenton's growth chart)

Exclusion Criteria

  • •Major congenital abnormality including severe cleft lip and palate.
  • •Babies requiring NICU admission immediately after birth
  • •Babies less than 34 weeks of age.
  • •Babies whose parents refused to consent

Arms & Interventions

CONTROL

No Intervention

Infants at risk for transient neonatal hypoglycemia following standard-of-care.

Tahneek

Experimental

Infants receiving a single dose of soft date, prepacked by the pharmacy containing glucose equivalent to 200mg/kg at 1 hour after birth in the nursery.

Intervention: Tahneek (Other)

Outcomes

Primary Outcomes

Admission to NICU for hypoglycemia

Time Frame: first 48 hours of life

infants at-risk will be followed to measure NICU admission data and glucose values during hospitalization.

Hypoglycemia

Time Frame: first 48 hours of life

infants who meet eligibility criteria and parents have consented will receive a single dose of soft date, prepacked by the pharmacy containing glucose equivalent to 200mg/kg within 1 h after birth. Assess glucose level after 1 feed compared to controls with similar risk factors who are not received Tahneek. hypoglycemia defined as any blood glucose concentration \< 2.6 mmol/L.

Secondary Outcomes

  • Breastfeeding(6 months)
  • Pain scale(48 hours)
  • Hyperglycemia(48 hours)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jubara Alallah

Assistant Professor of Pediatrics

King Abdullah International Medical Research Center

Study Sites (1)

Loading locations...

Similar Trials